Showing results (241-250 of 1,557) with videos related to
Sort By:
Pageof 156
Current Drug Targets|September 16, 2014
Optimizing conventional medical therapies in inflammatory bowel disease in 2014Anil Kumar Asthana, Miles P Sparrow, Laurent Peyrin-BirouletClinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 9, 2019
Use of Cross-Sectional Imaging for Tight Monitoring of Inflammatory Bowel DiseasesMariangela Allocca, Silvio Danese, Valérie Laurent, et al.Expert Opinion on Emerging Drugs|March 10, 2020
Emerging therapies for the treatment of ulcerative colitisNicola Pugliese, Giulia Roda, Laurent Peyrin-Biroulet, et al.Alimentary Pharmacology & Therapeutics|October 30, 2019
Inflammatory bowel disease: estimates from the global burden of disease 2017 studyDaniele Piovani, Silvio Danese, Laurent Peyrin-Biroulet, et al.Expert Review of Clinical Immunology|February 7, 2018
Vedolizumab for the treatment of Crohn's diseaseMarjorie Argollo, Gionata Fiorino, Laurent Peyrin-Biroulet, et al.Expert Opinion on Biological Therapy|August 29, 2020
Nocebo effect and biosimilars in inflammatory bowel diseases: what's new and what's next?Ferdinando D'Amico, Virginia Solitano, Laurent Peyrin-Biroulet, et al.Journal of Crohn'S & Colitis|November 18, 2021
Positioning Filgotinib in the Treatment Algorithm of Moderate to Severe Ulcerative ColitisFerdinando D'Amico, Fernando Magro, Laurent Peyrin-Biroulet, et al.Best Practice & Research. Clinical Gastroenterology|June 11, 2014
Treatment algorithms in Crohn's - up, down or something else?Ophélie Antunes, Jérôme Filippi, Xavier Hébuterne, et al.Current Opinion in Pharmacology|October 22, 2025
Targeting the unmet needs in IBD: Emerging therapies beyond biologics and small moleculesFabrizio Fanizzi, Laurent Peyrin-Biroulet, Silvio Danese, et al.Clinical and Experimental Gastroenterology|October 6, 2025
Optimising Monoclonal Antibody Drug Development for Inflammatory Bowel DiseaseMichael Colwill, Sailish Honap, Silvio Danese, et al.Pageof 156